Outcome predictors in nitric oxide treated preterm infants

Eur J Pediatr. 1999 Jul;158(7):589-91. doi: 10.1007/s004310051153.

Abstract

Our aim was to identify factors predictive of death in preterm infants in whom inhaled nitric oxide was administered in response to poor oxygenation (oxygenation index > or =15). Of the 23 (median gestational age 28 weeks, range 24-36) infants consecutively so treated, 15 died. Non-survival was commoner in infants with air leaks (12 of 12, P < 0.002) and/or a change in their oxygenation index of less than 30% in response to inhaled nitric oxide administration (P < 0.05).

Conclusion: In preterm infants given inhaled nitric oxide because of poor oxygenation, a diagnosis of airleak and a lack of initial response are predictive of death.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Chi-Square Distribution
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Male
  • Nitric Oxide / administration & dosage*
  • Nitric Oxide / adverse effects
  • Oxygen Consumption
  • Predictive Value of Tests
  • Respiratory Distress Syndrome, Newborn / diagnosis
  • Respiratory Distress Syndrome, Newborn / drug therapy*
  • Respiratory Distress Syndrome, Newborn / mortality*
  • Statistics, Nonparametric
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome

Substances

  • Nitric Oxide